Fluocinolone Acetonide Oil
Product Images NDC 72162-2319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fluocinolone Acetonide (NDC 72162-2319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (721622319extenedlabel)

Extended Label (721622319extenedlabel)
This text provides dosage and administration instructions for using Fluocinolone Acetonide Topical Oil, 0.01% to treat atopic dermatitis in pediatric patients 3 months and older, as well as atopic eczema/dermatitis in adults. The recommended application involves moistening the skin and applying the oil as a thin film to the affected areas. For pediatric patients, it is suggested to apply the oil twice daily for up to 4 weeks, while for adults, it is recommended to apply the oil three times daily.*
FDA Label Image

Structure (Fluocinolone Acetonide Chemical Structure)

FDA Label Image

Label (Lbl721622319)

Label (Lbl721622319)
This is a description of a topical medication containing Fluocinolone Acetonide (0.01%) in Isopropyl Alcohol (1.6%) solution. The formulation includes Refined Peanut Oil NF, Light Mineral Oil NF, and Isopropyl Myristate NF. It is recommended to shake well before use and not use with oil occlusion. The medication should be stored at room temperature (25°C), tightly closed, and out of reach of children. This product is suitable for topical use only and should not be used orally, in the eyes, or intravaginally. Additional information can be found on the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.